Beamtree Holdings Ltd (BMT) AI Stock Analysis

• Market Cap: AU$42.14M
• Dividend Yield: N/A
• Average Volume (3M): 122.51K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.86
• Revenue Growth: 3.61%
• EPS Growth: -17.03%
• Country: AU
• Employees: 97
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.01
• Shares Outstanding: 290,643,220
• 10 Day Avg. Volume: 152,204
• 30 Day Avg. Volume: 122,509
• PEG Ratio: -0.66
• Price to Book (P/B): 1.72
• Price to Sales (P/S): 2.53
• P/FCF Ratio: -39.18
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.30
• Price Target Upside: 36.36% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: AU$0.15 ▼(-33.64% Downside)
• Action: Reiterated Date: 02/21/26
• Date: Action: Reiterated 02/21/26

The score is primarily driven down by weak financial performance (loss-making operations, negative revenue growth, and cash flow strain) and bearish technical momentum (price below key moving averages with negative MACD). Valuation is only modestly supportive because the negative P/E reflects current losses and dividend yield is unavailable.

Positive Factors

Business model & market focus

Beamtree’s core offering—capturing and structuring clinical information for hospitals—aligns with long-term digitisation in healthcare. Structural demand for coding, documentation quality and decision support creates sticky, enterprise relationships and recurring revenue potential once adoption scales.

Very high gross margin

A 100% gross margin implies the business has very low incremental costs for its products, consistent with software/data-led models. This margin profile supports scalable unit economics and potential for operating leverage if sales growth and operating efficiency improve.

Conservative leverage / capital structure

A low debt load and stable equity ratio provide financial flexibility to invest in R&D or product rollouts and to withstand cash-flow volatility. Conservative leverage reduces default and refinancing risk, supporting long-term strategic options including partnerships or tuck-in M&A.

Negative Factors

Negative profitability & margins

Persistent negative EBIT and EBITDA indicate the company is not yet converting top-line into sustainable operating profits. Continued operating losses can erode cash reserves, limit reinvestment capacity, and require structural cost or revenue improvements to reach self-sustaining operations.

Weak cash generation

Negative free cash flow growth and poor cash conversion point to liquidity pressure and reliance on external funding to support operations. Weak cash generation constrains ability to fund product development, sales expansion or absorb market shocks without dilutive financing.

Revenue growth has turned negative

A reversal to negative revenue growth signals weakening market demand or competitive loss. Declining top-line undermines economies of scale and the company’s ability to leverage its high gross margins into profit, making sustained turnaround dependent on regaining growth or restructuring.

Beamtree Holdings Ltd Business Overview & Revenue Model

Company Description

Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records. The company offers advisory and auditing solution, such as desktop analysis, data maturity index, and physical audits. It serves customers through channel partners. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. Beamtree Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.

How the Company Makes Money

Beamtree Holdings Ltd generates revenue primarily through the sale of its software solutions and data analytics services to healthcare providers, including hospitals, clinics, and mental health organizations. The company adopts a subscription-based model for many of its products, allowing clients to access its platforms for a recurring fee, which provides predictable revenue streams. Additionally, BMT may earn income through consulting services related to the implementation and optimization of their software. Strategic partnerships with healthcare institutions and technology firms also contribute to its earnings, as they can lead to joint ventures, co-development projects, and expanded market reach.

Beamtree Holdings Ltd Financial Statement Overview

Summary

Financial health is weak: the income statement shows negative profitability (negative EBIT/EBITDA margins) and revenue growth has turned negative. Cash flow is also pressured with negative free cash flow metrics and poor cash conversion. The balance sheet is comparatively steadier with conservative leverage, but negative ROE remains a key concern.

Income Statement

Beamtree Holdings Ltd shows a concerning trend in its income statement, with negative net profit margins and declining revenue growth. The gross profit margin is strong at 100%, but the company is struggling with negative EBIT and EBITDA margins, indicating operational inefficiencies. The revenue growth rate has turned negative, suggesting a potential decline in market demand or competitive pressures.

Balance Sheet

The balance sheet reflects a relatively low debt-to-equity ratio, indicating conservative leverage. However, the return on equity is negative, pointing to inefficiencies in generating returns for shareholders. The equity ratio is stable, suggesting a solid capital structure, but the negative ROE is a significant concern.

Cash Flow

Cash flow analysis reveals challenges with negative free cash flow growth and a low operating cash flow to net income ratio. The free cash flow to net income ratio is also negative, highlighting cash generation issues. These factors suggest potential liquidity constraints and the need for improved cash management.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	28.90M	28.60M	27.60M	22.77M	16.55M	8.39M
Gross Profit	1.66M	28.60M	4.89M	2.14M	-202.00K	2.77M
EBITDA	-4.74M	-808.00K	-331.00K	-1.26M	-2.28M	1.02M
Net Income	-5.78M	-6.16M	-5.11M	-6.91M	-4.45M	-383.62K
Balance Sheet
Total Assets	53.26M	54.29M	59.65M	62.53M	63.91M	47.05M
Cash, Cash Equivalents and Short-Term Investments	2.94M	4.78M	5.04M	8.81M	6.35M	14.12M
Total Debt	3.65M	3.26M	1.66M	755.00K	1.12M	799.36K
Total Liabilities	13.76M	12.36M	12.52M	15.31M	15.33M	4.96M
Stockholders Equity	39.51M	41.93M	47.14M	47.22M	48.58M	42.09M
Cash Flow
Free Cash Flow	906.00K	-1.84M	-4.51M	-1.88M	-4.83M	-2.64M
Operating Cash Flow	1.08M	609.00K	-492.00K	768.00K	-2.32M	240.65K
Investing Cash Flow	-3.37M	-2.45M	-4.02M	-2.65M	-5.16M	-2.98M
Financing Cash Flow	1.54M	1.58M	749.00K	4.34M	-286.00K	12.65M

Beamtree Holdings Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.22
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:BMT, the sentiment is Negative. The current price of 0.22 is above the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.19, and below the 200-day MA of 0.23, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 32.30 is Neutral, neither overbought nor oversold. The STOCH value of 12.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:BMT.

Beamtree Holdings Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALC	67 Neutral	AU$134.30M	83.33	1.89%	―	10.06%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
M7T	48 Neutral	AU$79.90M	-13.18	-12.35%	―	15.99%	22.05%
RHT	46 Neutral	AU$20.42M	-11.32	-17.05%	―	28.91%	-1050.00%
PCK	45 Neutral	AU$36.58M	-4.00	-8647.54%	―	25.98%	22.10%
BMT	44 Neutral	AU$42.14M	-7.29	-13.83%	―	3.61%	-17.03%

Beamtree Holdings Ltd Corporate Events

Beamtree Sets Date for 1H FY26 Results and Investor Webinar

Beamtree Holdings Limited has announced that it will release its half-year results for the first half of FY26 on 25 February 2026 and will host an investor webinar the same day at 9:00am AEST to discuss the performance. The scheduled update underscores the company’s ongoing communication with investors as it pursues growth in AI-enabled healthcare analytics and decision support, with stakeholders likely to focus on how its diversified product segments are translating into operational and financial progress in a competitive digital health landscape.

The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

Beamtree Seeks ASX Quotation for New Shares Issued Under Employee Plan

Beamtree Holdings Limited has applied for quotation on the ASX of 46,045 new fully paid ordinary shares issued on 13 January 2026 under its Employee Incentive Plan, pursuant to salary contribution arrangements. The modest equity issuance reflects the company’s ongoing use of share-based remuneration to align staff interests with shareholders, signalling continued emphasis on talent retention and engagement without materially altering the company’s capital structure.

The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.22 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

Beamtree Issues 1 Million Unquoted Performance Rights Under Employee Incentive Plan

Beamtree Holdings Limited has issued 1,000,000 unquoted performance rights under its employee incentive scheme, with the new securities designated under ASX code BMTAC and issued on 9 January 2026. The performance rights are subject to transfer restrictions and will not be quoted on the ASX until those restrictions lapse, indicating the company’s ongoing use of equity-based remuneration to retain and motivate staff while limiting immediate market dilution.

The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.22 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

Beamtree Issues 700,000 Unquoted Performance Rights Under Employee Incentive Scheme

Beamtree Holdings Limited has notified the market of the issue of 700,000 unquoted performance rights under its employee incentive scheme, with an issue date of 14 November 2025. The new equity allocation forms part of Beamtree’s strategy to align staff and executive remuneration with long-term shareholder value, using equity-based incentives that are subject to trading restrictions and are not quoted on the ASX, thereby reinforcing retention and performance objectives without immediately diluting the quoted share base.

The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.22 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

Beamtree Holdings Announces Amended Constitution Approval

Beamtree Holdings Limited has announced the approval of its amended Constitution following a special resolution by shareholders at the recent Annual General Meeting. This development signifies a strategic move that may impact the company’s governance structure and operational framework, potentially influencing its market positioning and stakeholder relations.

The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.22 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

Beamtree Holdings Secures Shareholder Approval for All AGM Resolutions

Beamtree Holdings Limited announced that all resolutions were passed by shareholders at their Annual General Meeting. This outcome reflects strong shareholder support and may positively influence the company’s strategic direction and governance, reinforcing its industry position and stakeholder confidence.

The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

Beamtree Holdings Unveils Strategic Innovations and Leadership Appointments at 2025 AGM

Beamtree Holdings Limited held its 2025 Annual General Meeting, highlighting significant innovations and strategic leadership appointments. The company announced the successful launch of its data analytics platform in Australia, with plans to expand into the UK market in early 2026 in partnership with the UK NHS Confederation. Additionally, Beamtree’s Picq Audit product has achieved strong market fit and is expanding from the public to the private sector and internationally, with revenue exceeding expectations.

The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.

Beamtree Holdings Strengthens Executive Team with Key Appointments

Beamtree Holdings Limited has announced the appointment of Michelle Spiller as Chief Financial Officer and James Price as General Manager Sales for Australia and New Zealand. Michelle brings a wealth of experience in financial management and strategic planning from her previous roles in ASX-listed technology companies, while James has a strong background in health, aged care, and technology sectors. These appointments are expected to strengthen Beamtree’s executive team, enhance its operational and strategic priorities, and bolster its focus on core solutions and customer service in key markets.

The most recent analyst rating on (AU:BMT) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.